GetTopicDetailResponse(id=6ccd12428920, topicName=KMT2A, introduction=, content=含地西他濱 KMT2A, image=null, comments=0, allHits=272, url=null, type=0, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Sun Feb 16 16:38:20 CST 2025, time=2025-02-16, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=501556, tagList=[TagDto(tagId=501556, tagName=KMT2A)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2270658, encodeId=fed222e06588f, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=6ccd12428920' target=_blank style='color:#2F92EE;'>#KMT2A#</a>, objectTitle=【Cancer】浙一醫(yī)院研究證實(shí)KRAS突變狀態(tài)影響KMT2A重排AML的預(yù)后, objectType=article, longId=883863, objectId=ec0d883863a7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202238/1646707301578_5552845.jpg, objectUrl=/article/show_article.do?id=ec0d883863a7, replyNumber=0, likeNumber=33, createdTime=2025-06-24, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ec0d883863a7, moduleTitle=【Cancer】浙一醫(yī)院研究證實(shí)KRAS突變狀態(tài)影響KMT2A重排AML的預(yù)后, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ec0d883863a7)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2268455, encodeId=9a902268455b4, content=<a href='/topic/show?id=9370233531' target=_blank style='color:#2F92EE;'>#Allo-HSCT#</a> <a href='/topic/show?id=6ccd12428920' target=_blank style='color:#2F92EE;'>#KMT2A#</a>, objectTitle=【BJH】化療后監(jiān)測(cè)KMT2A基因可預(yù)測(cè)異基因移植后的復(fù)發(fā)和生存, objectType=article, longId=881418, objectId=a93d88141814, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240510/1715333804484_5579292.png, objectUrl=/article/show_article.do?id=a93d88141814, replyNumber=0, likeNumber=22, createdTime=2025-06-08, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a93d88141814, moduleTitle=【BJH】化療后監(jiān)測(cè)KMT2A基因可預(yù)測(cè)異基因移植后的復(fù)發(fā)和生存, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=a93d88141814)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2265848, encodeId=c9c8226584883, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=6ccd12428920' target=_blank style='color:#2F92EE;'>#KMT2A#</a>, objectTitle=【BCJ】KMT2A (MLL)重排AML結(jié)局及影響因素的中國(guó)真實(shí)世界研究, objectType=article, longId=878169, objectId=17aa8e8169f4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20231112/1699803768993_5579292.jpg, objectUrl=/article/show_article.do?id=17aa8e8169f4, replyNumber=0, likeNumber=33, createdTime=2025-05-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=17aa8e8169f4, moduleTitle=【BCJ】KMT2A (MLL)重排AML結(jié)局及影響因素的中國(guó)真實(shí)世界研究, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=17aa8e8169f4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2265850, encodeId=84952265850b6, content=<a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a> <a href='/topic/show?id=6ccd12428920' target=_blank style='color:#2F92EE;'>#KMT2A#</a>, objectTitle=【Leukemia】MD安德森癌癥中心新診斷KMT2A重排AML的特征及結(jié)局, objectType=article, longId=878177, objectId=549b8e81774b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220804/1659603269411_8252897.webp, objectUrl=/article/show_article.do?id=549b8e81774b, replyNumber=0, likeNumber=33, createdTime=2025-05-20, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=549b8e81774b, moduleTitle=【Leukemia】MD安德森癌癥中心新診斷KMT2A重排AML的特征及結(jié)局, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=549b8e81774b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2252206, encodeId=6f1722522063f, content=<a href='/topic/show?id=1ee3124288dd' target=_blank style='color:#2F92EE;'>#含地西他濱#</a> <a href='/topic/show?id=6ccd12428920' target=_blank style='color:#2F92EE;'>#KMT2A#</a>, objectTitle=中國(guó)多中心研究在KMT2A重排白血病中對(duì)比含地西他濱強(qiáng)化預(yù)處理與標(biāo)準(zhǔn)清髓性預(yù)處理, objectType=article, longId=863498, objectId=bbf786349843, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241127/1732686226246_8538692.jpg, objectUrl=/article/show_article.do?id=bbf786349843, replyNumber=0, likeNumber=33, createdTime=2025-02-16, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=bbf786349843, moduleTitle=中國(guó)多中心研究在KMT2A重排白血病中對(duì)比含地西他濱強(qiáng)化預(yù)處理與標(biāo)準(zhǔn)清髓性預(yù)處理, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=bbf786349843)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2025-02-16發(fā)表于陜西省
